Glucocorticoids Inhibit the Autoregulatory Induction of lnterleukin-1 in Monocytes after Endotoxin Stimulation
Interleukin-l (IL-1) is an important mediator in the mechanisms underlying the immune and inflammatory responses. It has pleiotropic effects in host defense and, when present in high concentrations, participates in the development of pathological processes. IL-1 is the most potent cytokine in the ac...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
1996
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 12818caa a22011657a 4500 | ||
|---|---|---|---|
| 001 | PAPER-3308 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203246.0 | ||
| 008 | 190411s1996 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-12644271901 | |
| 024 | 7 | |2 cas |a dexamethasone, 50-02-2; hydrocortisone, 50-23-7; mifepristone, 84371-65-3; Endotoxins; Glucocorticoids; Interleukin-1; Lipopolysaccharides | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 100 | 1 | |a Pereda, M.P. | |
| 245 | 1 | 0 | |a Glucocorticoids Inhibit the Autoregulatory Induction of lnterleukin-1 in Monocytes after Endotoxin Stimulation |
| 260 | |c 1996 | ||
| 270 | 1 | 0 | |m Arzt, E.; Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Buenos Aires, Donato Alvarez 3150, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Dinarello, C.A., Interleukin-1 and interleukin-1 antagonism (1991) Blood, 77, pp. 1627-1652 | ||
| 504 | |a Oppenheim, J.J., Kovacs, E.J., Matsushima, K., Durum, S.K., There is more than one interleukin 1 (1986) Immunol Today, 7, pp. 45-56 | ||
| 504 | |a Dinarello, C.A., Ikejima, T., Warner, S., Oren-Eole, S.F., Lonncmann, G., Cannon, J.G., Libby, P., Interleukin I induces interleukin 1, I, Induction of circulating interleukin I in rabbits in vivo and in human mononuclear cells in vitro (1987) J Immunol, 139, pp. 1902-1910 | ||
| 504 | |a Warner, S., Auger, K.R., Libby, P., Intcrlcukin-I induces interleukin-1, II, Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells (1987) J Immunol, 139, pp. 1911-1917 | ||
| 504 | |a Warner, S., Auger, K.R., Libby, P., Human inter-lcukin-1 induces interleukin-1 gene expression in human vascular smooth muscle cells (1987) J Exp Med, 165, pp. 1316-1331 | ||
| 504 | |a Dinarello, C.A., Role of interleukin-1 in infectious diseases (1992) Immunol Rev, 127, pp. 119-146 | ||
| 504 | |a Thompson, R.C., Dripps, D.J., Eisenberg, S.P., Interleukin-! receptor antagonist (11.-Ira) as a probe and as a treatment for IL-1 mediated disease (1992) Int J Immunopharmacol, 14, pp. 475-480 | ||
| 504 | |a Van Zee, K.J., Coyle Calvano, S.M., Oldenburg, H., Stiles, D.M., Pribble, J., Catalano, M., Mol-Dawer, L.L., Lowry, S.F., Influence of IL-I receptor blockade on the human response to endotox-emia (1995) J Immunol, 154, pp. 1499-1504 | ||
| 504 | |a Fisher, E., Marano, M.A., Van Zee, K.J., Rock, C.S., Hawes, A.S., Thompson, W.A., Deforge, L., Moldawer, L.L., Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia (1992) J Clin Invest, 89, pp. 1551-1557 | ||
| 504 | |a Conti, P., Panara, M.P., Fridas, S., Barbacane, R.C., Grilli, A., Placido, F.C., Reale, M., Fiore, S., Inhibition of granuloma formation induced by permanganate in the mouse by a specific human recombinant rcccptor antagonist for interleu-kin-1 (HrlL-lra) (1993) Cell Immunol, 147, p. 446 | ||
| 504 | |a Vidal-Vanadocha, F., Amczaga, C., Asumcndi, A., Kaplanski, G., Dinarello, C.A., Interleukin-1 receptor blockade reduces the number and size of murine BI6 melanoma hepatic mctastascs (1994) Cancer Res, 54, pp. 2667-2672 | ||
| 504 | |a Eisenberg, S.P., Evans, R.J., Arend, W.P., Verderber, E., Brewer, M.T., Hannum, C.H., Thompson, R.C., Primary structure and functional expression from complementary DNA of a human inter-lcukin-1 receptor antagonist (1990) Nature, 343, pp. 341-346 | ||
| 504 | |a Granowiu, E.V., Clark, B.D., Vannier, H., Callahan, M.V., Dinarello, C.A., Effect of interleukin-1 (IL-I) blockade on cytokine synthesis: I, IL-I rcccptor antagonist inhibits IL-l-induccd cytokine synthesis and blocks the binding of IL-1 to its tvpc II receptor on human monocytes (1992) Blood, 79, pp. 2356-2363 | ||
| 504 | |a Evans, R.J., Bray, J., Childs, J.D., Vigcrs, G., Brandhuber, B.J., Skalicky, J.J., Thompson, R.C., Eisenbcrg, S.P., Mapping rcccptor binding sites in interleukin (IL)-I rcccptor antagonist and IL-lp by site directed mutagenesis (1995) J Biol Chcm, 270, pp. 11477-11483 | ||
| 504 | |a Colotta, F., Re, F., Muzio, M., Bcrlini, R., Polenta-Rutti, N., Sironi, M., Giri, J.G., Mantovani, A., Lnterleukin-1 type 11 receptor: A decoy larger for IL-I that is regulated by IL-4 (1993) Science, 261, pp. 472-475 | ||
| 504 | |a Re, F., Muzio, M., De Rossi, M., Polentarutti, N., Mantovani, A., Colotta, F., The type II receptor as a decoy target for interleukin-1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding propert ies of the released decoy rcccptor (1994) J Exp Med, 179, pp. 739-743 | ||
| 504 | |a Poutsiaka, D.D., Clark, B.D., Vannier, E., Dinarello, C.A., Production of intcrlcukin-1 receptor antagonist and interleukin-1 (5 by peripheral blood mononuclear cells is differentially regulated (1991) Blood, 78, pp. 1275-1281 | ||
| 504 | |a Arend, W.P., Smith, M.F., Janson, R.W., Joslin, F.G., IL-1 rcccptor antagonist and IL-1 (3 production in human monocytes are regulated differently (1991) J Immunol, 147, pp. 1530-1536 | ||
| 504 | |a Ersson, L.B., Bjork, L., Dinarello, C.A., Towbin, H., Ersson, U., Lipopolysaccharidc induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell (1992) Eurj Immunol, 22, pp. 2617-2623 | ||
| 504 | |a Cupps, T.R., Fauci, A.S., Corticosteroid-mediated immunorcgulation in man (1982) Immunol Rev, 65, pp. 133-155 | ||
| 504 | |a Snyder, D.S., Unanue, E.R., Corticosteroids inhibit murine macrophage la expression and interleukin I production (1982) J Immunol, 129, pp. 1803-1805 | ||
| 504 | |a Lee, S.W., Tsou, A.P., Chan, H., Thomas, J., Petrie, K., Eugui, E.M., Allison, A.G., Glucocorticoids selectively inhibit the transcription of the interleukin ip gene and decrease the stability of interleukin ip mRNA (1988) Proc Natl Acad Sci USA, 85, pp. 1204-1208 | ||
| 504 | |a Bcscdovsky, H., Del Rev, A., Sorkin, E., Dinarcl-Lo, C.A., Immunorcgulatory feedback between interleukin-1 and glucocorticoid hormones (1986) Science, 233, pp. 652-654 | ||
| 504 | |a Arzt, E., Sauer, J., Pollmacher, T., Labeur, M., Llols-Bocr, F., Reul, J., Stalla, G.K., Glucocorticoids suppress interleukin-1 receptor antagonist synthesis follow ing induction by endotoxin (1994) Endocrinology, 134, pp. 672-677 | ||
| 504 | |a Sauer, J., Castren, M., Hopfner, U., Holsboer, F., Stalla, G.K., Arzt, E., Inhibition of lipopolysac-charide-induccd monocyte interleukin-1 rcccptor antagonist synthesis by cortisol: Involvement of the mineralocorticoid receptor (1996) J Clin Endocrinol Metab, 81, pp. 73-79 | ||
| 504 | |a Arzt, E., Fernández, C.S., Finocchiaro, L., Criscuolo, M., Diaz, A., Finkielman, S., Nahmod, V.E., Immunomodulation by indolcamincs: Serotonin and melatonin action on DNA and interferon gamma synthesis by human peripheral blood mononuclear cells (1988) J Clin Immunol, 8, pp. 513-519 | ||
| 504 | |a Sayers, G., The adrenal cortex and homeostasis (1950) Physiol Rev, 30, pp. 241-320 | ||
| 504 | |a Schrcibcr, W., Pollmacher, T., Fassbcnder, K., Gu-Dcwill, S., Vcdder, H., Wiedemann, K., Galanos, C., Holsboer, F., Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol: A comparative study in men (1993) Ncu-Roendoerinology, 58, pp. 123-128 | ||
| 504 | |a Arzt, E., Stclzer, G., Renner, U., Lange, M., Müller, O.A., Stalla, G.K., Interleukin-2 and interleukin-2 rcccptor expression in human corticotrophic adenoma and murine pituitary cell cultures (1992) J Clin Invest, 90, pp. 1944-1951 | ||
| 504 | |a Nishida, T., Nishino, N., Takano, M., Kawai, K., Bando, K., Masui, Y., Nakai, S., Hirai, Y., CDNA cloning of IL-I a and IL-ip from mRNA of U937 cell line (1987) Biochcm Biophys Res Commun, 143, pp. 345-352 | ||
| 504 | |a Granowitz, E.V., Vannier, E., Poutsiaka, D.D., Dinarello, C.A., Effect ofintcrleukin-1 (IL-1) blockade on cytokine synthesis: II, IL-l rcccptor antagonist inhibits lipopolysaccharide-induecd cytokinc synthesis by human monocytes (1992) Blood, 79, pp. 2364-2369 | ||
| 504 | |a Ishikawa, Y., Mukaida, N., Kuno, K., Rice, N., Oka-Moto, S., Matsushima, K., Establishment of lipo-polysaccharidc-dcpcndcnt nuclear factor kB activation in a cell-free system (1995) J Biol Chem, 270, pp. 4158-4164 | ||
| 504 | |a McKcan, D.J., Bell, M., Huntoon, C., Rastogi, S., Van Norstrand, M., Podzorski, R., Nilson, A., Paya, C., IL-I rcccptor and TCR signals syner-gizc to activate NF-KB-mediatcd gene transcription (1995) Int Immunol, 7, pp. 9-20 | ||
| 504 | |a Serkkola, E., Hurme, M., Synergism between pro-tcin-kinasc C and cAMP-dependent pathways in the expression of the interleukin-ip gene is mediated via the activator-protein-1 (AP-1) enhancer activity (1993) Eurj Biochem, 213, pp. 243-249 | ||
| 504 | |a Albrightson, C.R., Bacnziger, N.L., Needleman, P., Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: Role of monokines and interleukin 1 (1985) J Immunol, 135, pp. 1872-1877 | ||
| 504 | |a Knudsen, P.J., Dinarello, C.A., Strom, T.B., Prostaglandins posttranseriptionally inhibit mono-cvtc expression of interleukin I activity by increasing intracellular cyclic adenosine monophosphate (1986) J Immunol, 137, pp. 3189-3194 | ||
| 520 | 3 | |a Interleukin-l (IL-1) is an important mediator in the mechanisms underlying the immune and inflammatory responses. It has pleiotropic effects in host defense and, when present in high concentrations, participates in the development of pathological processes. IL-1 is the most potent cytokine in the activation of the hypothalamic-pituitary-adrenal axis during infection and therefore leads to a glucocorticoid increase. Glucocorticoids in a feedback loop inhibit the production of IL-1 induced by endotoxin. IL-1 also induces its own synthesis. In this report, we examine the role of glucocorticoids in the regulation of IL-1 autoregulatory induction in human monocytes at the level of IL-1 protein production and mRNA accumulation. Using recombinant IL1 receptor antagonist we established that endogenously produced IL-1 affects induction of IL-1βprotein by lipopolysaccharide (LPS) at the level of mRNA expression. The inhibition of LPS-stimulated IL-1βproduction and mRNA expression by glucocorticoids (dexamethasone and Cortisol) reaches the same level with glucocorticoids alone or in combination with rIL-1ra. IL-1βmRNA induced by exogenously added IL-1βwas also inhibited by glucocorticoids. These results indicate that glucocorticoids inhibit the autoregulatory loop of IL-1 in LPS-stimulated monocytes and constitute a mechanism for controlling IL-1 feedback stimulation. © 1996 S. Karger AG, Basel. |l eng | |
| 593 | |a Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Buenos Aires, Argentina | ||
| 593 | |a Max Planck Institute of Psychiatry, Clinical Institute, Munich, Germany | ||
| 593 | |a Departamento de Biologia, FCEN, Universidad de Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a ENDOTOXIN |
| 690 | 1 | 0 | |a GLUCOCORTICOIDS |
| 690 | 1 | 0 | |a INTERLEUKIN-L |
| 690 | 1 | 0 | |a MONOCYTES |
| 690 | 1 | 0 | |a DEXAMETHASONE |
| 690 | 1 | 0 | |a GLUCOCORTICOID |
| 690 | 1 | 0 | |a HYDROCORTISONE |
| 690 | 1 | 0 | |a INTERLEUKIN 1 RECEPTOR BLOCKING AGENT |
| 690 | 1 | 0 | |a INTERLEUKIN 1BETA |
| 690 | 1 | 0 | |a LIPOPOLYSACCHARIDE |
| 690 | 1 | 0 | |a MESSENGER RNA |
| 690 | 1 | 0 | |a MIFEPRISTONE |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a MONOCYTE |
| 690 | 1 | 0 | |a NORMAL HUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a CELLS, CULTURED |
| 690 | 1 | 0 | |a DOSE-RESPONSE RELATIONSHIP, DRUG |
| 690 | 1 | 0 | |a ENDOTOXINS |
| 690 | 1 | 0 | |a GLUCOCORTICOIDS |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a INTERLEUKIN-1 |
| 690 | 1 | 0 | |a LIPOPOLYSACCHARIDES |
| 690 | 1 | 0 | |a MONOCYTES |
| 650 | 1 | 7 | |2 spines |a HOMEOSTASIS |
| 653 | 0 | 0 | |a ru 38486, roussel uclaf, France |
| 700 | 1 | |a Castro, C.P. | |
| 700 | 1 | |a Costas, M. | |
| 700 | 1 | |a Nahmod, V.E. | |
| 700 | 1 | |a Stalla, G.K. | |
| 700 | 1 | |a Holsboer, F. | |
| 700 | 1 | |a Arzt, E. | |
| 773 | 0 | |d 1996 |g v. 3 |h pp. 227-232 |k n. 4 |p NeuroImmunomodulation |x 10217401 |t NeuroImmunoModulation | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-12644271901&doi=10.1159%2f000097275&partnerID=40&md5=511b2f47aad43a0fbe025b14d5f512bd |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000097275 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_10217401_v3_n4_p227_Pereda |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10217401_v3_n4_p227_Pereda |y Registro en la Biblioteca Digital |
| 961 | |a paper_10217401_v3_n4_p227_Pereda |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 64261 | ||